Adar Poonawalla, chief executive officer of Serum Institute of India (SII), expects the restrictions on export of Covid vaccines to ease within two months, provided that India has created enough stockpile to weather a third wave.
Raw material supplies for the Novavax vaccine have improved compared to March, and SII plans to announce its monthly production plan in December, Poonawalla told the media on Friday.
“There was no ban on exports, but there were temporary restrictions, and rightly so. I think these will slowly ease in the next month or two, but I don’t want to venture a guess. But it will